9,026
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts

ORCID Icon, , , , , & show all
Article: 1886455 | Received 11 Jun 2020, Accepted 02 Feb 2021, Published online: 19 Feb 2021

References

  • UNAIDS. Global HIV and AIDS statistics 2019 fact sheet. Global HIV AIDs ststistics, World AIDS day 2019 Fact Sheet; 2019. https://www.unaids.org/en/resources/fact-sheet.
  • Simbayi, L., Zuma, K., Zungu, N., Moyo, S., Marinda, E., Jooste, S., Mabaso, M., Ramlagan, S., North, A., Van Zyl, J., Mohlabane, N., Dietrich, C., Naidoo, I. & the SABSSM V, Team (2019) South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017: towards achieving the UNAIDS 90-90-90 targets. Cape Town: HSRC Press. https://www.hsrcpress.ac.za/books/south-african-national-hiv-prevalence-incidence-behaviour-and-communication-survey-2017.
  • Human Sciences Research Council. Hiv impact assessment summary July 2018 the fifth South African national HIV prevalence, incidence, behaviour and communication survey, 2017. 2018;2017:5–10.
  • Marcus, J.L., Buisker, T., Horvath, T., Amico, K.R., Fuchs, J.D., Buchbinder, S.P., Grant, R.M. and Liu, A.Y., 2014. Helping our patients take HIV pre‐exposure prophylaxis (PrEP): a systematic review of adherence interventions. HIV medicine, 15(7), pp.385-395.
  • Straubinger T, Kay K, Bies R. Modeling HIV pre-exposure prophylaxis. Front Pharmacol. 2020;10:1–12.
  • Venter WDF, Cowan F, Black V, et al. Pre-exposure prophylaxis in Southern Africa: feasible or not? J Int AIDS Soc. 2015;18:1–7.
  • Rojas Castro D, Delabre RM, Molina JM. Give PrEP a chance: moving on from the ‘risk compensation’ concept. J Int AIDS Soc. 2019;22:50–56.
  • Haberer JE, Mugo N, Baeten JM, et al. PrEP as a lifestyle and investment for adolescent girls and young women in Sub-Saharan Africa. J Int Assoc Provid AIDS Care. 2019;18:1–5.
  • Pilgrim N, Mathur S, Gottert A, et al. Building evidence to guide PrEP introduction for adolescent girls and young women. Popul Counc. 2016;3:44.
  • Kamitani E, Mizuno Y, Wichser M, et al. Mapping the study characteristics and topics of hiv pre-exposure prophylaxis research literature: a scoping review. AIDS Educ Prev. 2019;31:505–522.
  • Singh S, Song R, Johnson AS, et al. HIV incidence, prevalence, and undiagnosed infections in U.S. Men who have sex with men. Ann Internal Med. 2018;168:685.
  • Beyrer C, Baral, SD, Van Griensven, F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012. DOI:https://doi.org/10.1016/S0140-6736(12)60821-6
  • Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.
  • Mabaso M, Sokhela Z, Mohlabane N, et al. Determinants of HIV infection among adolescent girls and young women aged 15-24 years in South Africa: a 2012 population-based national household survey. BMC Public Health. 2018;18. DOI:https://doi.org/10.1186/s12889-018-5051-3
  • Zuma K, Shisana O, Rehle TM, et al. New insights into HIV epidemic in South Africa: key findings from the national HIV prevalence, incidence and behaviour survey, 2012. African J AIDS Res. 2016;15:67–75.
  • Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, et al. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health. 2018;15:489.
  • World Health Organization. Pre-exposure prophylaxis(PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection. Geneva: WHO. 2015.
  • Ortblad KF, Stalter RM, Bukusi EA, Ngure K, Mujugura A, Celum C, Baeten JM, Heffron R. No evidence of sexual risk compensation following PrEP initiation among heterosexual HIV serodiscordant couples in Kenya and Uganda. AIDS and Behavior. 2019 Nov 6:1-1.
  • Gomez GB, Borquez A, Case KK, et al. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med. 2013;10:e1001401.
  • Grace D, Jollimore J, MacPherson P, et al. The pre-exposure prophylaxis-stigma paradox: learning from Canada’s first wave of PrEP users. AIDS Patient Care STDS. 2018;32:24–30.
  • Smith DK, Mendoza MCB, Stryker JE, et al. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009-2015. PLoS One. 2016;11:e0156592.
  • Wheelock A, Eisingerich AB, Gomez GB, et al. Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study. BMJ Open. 2012;2:e001234.
  • Eaton LA, Driffin DD, Smith H, et al. Psychosocial factors related to willingness to use pre-exposure prophylaxis for HIV prevention among Black men who have sex with men attending a community event. Sex Health. 2014;11:244.
  • Shamu S, Khupakonke S, Farirai T, et al. Knowledge, attitudes and practices of young adults towards HIV prevention: an analysis of baseline data from a community-based HIV prevention intervention study in two high HIV burden districts, South Africa. BMC Public Health. 2020;20. DOI:https://doi.org/10.1186/s12889-020-09356-3
  • Shamu S, Kuwanda L, Farirai T, et al. Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa. PLoS One. 2019;14:e0217836.
  • Joint United Nations Programme on HIV AIDS. Global aids response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on HIV and AIDS. New York: UNAIDS. 2014.
  • Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2012. Cape Town: HSRC. 2014.
  • Harris PA. Research Electronic Data Capture (REDCap) - planning, collecting and managing data for clinical and translational research. BMC Bioinformatics. 2012;13:A15.
  • Harris CJ, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
  • StataCorp. Stata statistical software: release 13. 2013. DOI:https://doi.org/10.2307/2234838
  • Tellalian D, Maznavi K, Bredeek UF, et al. Pre-exposure prophylaxis (prep) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27:553–559.
  • Desai M, Gafos M, Dolling D, et al. Healthcare providers’ knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. HIV Med. 2016;17:133–142.
  • Golub SA, Fikslin RA, Goldberg MH, et al. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23:1917–1924.
  • Hosmer LS. Applied logistic regression. 2nd ed. New York: Willey; 2000.
  • Hosek SG, Rudy B, Landovitz R, et al. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr. 2017;74:21–29.
  • McMahon JM, Myers JE, Kurth AE, et al. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS. 2014;28:462–474.
  • Vaccher S, Grulich A, McAllister J, et al. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW demonstration project PRELUDE. BMJ Open. 2016;6:e012179.
  • Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2:e512–e519.
  • Koechlin FM, Fonner VA, Dalglish SL, et al. Values and preferences on the use of oral Pre-exposure Prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21:1325–1335.
  • Syvertsen JL, Bazzi AM, Scheibe A, Adebajo S, Strathdee SA, Wechsberg WM. The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workers. African journal of reproductive health. 2014;18(3):74-83.
  • Fong OW, Ho CF, Fung LY, et al. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med. 2003;4:133–138.
  • Palepu A, Tyndall MW, Chan K, Wood E, Montaner JS, Hogg RS. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antiviral therapy. 2004 Oct 1;9(5):713-720.
  • Witteveen E, Van Ameijden EJC. Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence. Subst Use Misuse. 2002;37:1905–1925.
  • Haberera JE, Bangsberg DR, Baeten JM, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29:1277–1285.
  • Chersich MF, Wabiri N, Risher K, et al. Contraception coverage and methods used among women in South Africa: a national household survey. South African Med J. 2017;107:307.
  • Akram W, Kumar R. A study on positive and negative effects of social media on society. Int J Comput Sci Eng. 2017. DOI:https://doi.org/10.26438/ijcse/v5i10.351354
  • Laroche M, Habibi MR, Richard MO, et al. The effects of social media based brand communities on brand community markers, value creation practices, brand trust and brand loyalty. Comput Human Behav. 2012;28:1755–1767.
  • Cohen J. A powerful and perplexing new HIV prevention tool. Science. 2010;330:1298–1299.
  • Khan AS, Fleischauer A, Casani J, et al. The next public health revolution: public health information fusion and social networks. Am J Public Health. 2010;100:1237–1242.
  • Griffiths F, Cave J, Boardman F, et al. Social networks - the future for health care delivery. Soc Sci Med. 2012;75:2233–2241.
  • Kalichman SC, Ntseane D, Nthomang K, et al. Recent multiple sexual partners and HIV transmission risks among people living with HIV/AIDS in Botswana. Sex Transm Infect. 2007;83:371–375.
  • Townsend L, Jewkes R, Mathews C, et al. HIV risk behaviours and their relationship to Intimate Partner Violence (IPV) among men who have multiple female sexual partners in Cape Town, South Africa. AIDS Behav. 2011;15:132–141.
  • World Health Organization. Guidelines on HIV self-testing and partner notification: supplement to consolidated guidelines on HIV testing services. World Health Organization. 2016. Geneva: WHO.
  • Gandhi NR, Moll AP, Lalloo U, et al. Successful integration of tuberculosis and HIV treatment in rural South Africa: the sizonq’oba study. J Acquir Immune Defic Syndr. 2009;50:37–43.
  • Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580.
  • Karim SSA, Churchyard GJ, Karim QA, et al. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374:921–933.